AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo
2020 ◽
Vol 121
◽
pp. 109502
◽
Keyword(s):
2014 ◽
Vol 66
(4)
◽
pp. 613-624
◽
Keyword(s):
2002 ◽
Vol 135
(8)
◽
pp. 1859-1871
◽
2013 ◽
Vol 134
(5)
◽
pp. 1239-1249
◽
Keyword(s):